Universe Pharmaceuticals (UPC) Short-term Investments (2021 - 2024)

Universe Pharmaceuticals (UPC) has 4 years of Short-term Investments data on file, last reported at $1.4 billion in Q3 2024.

• For the quarter ending Q3 2024, Short-term Investments rose 100691.56% year-over-year to $1.4 billion; the trailing twelve-month figure through Sep 2024 stood at $1.4 billion (up 100691.56% YoY), and the FY2024 full-year result was $1.4 billion, up 100691.56% from the prior year.
• Short-term Investments advanced to $1.4 billion in Q3 2024, from $2.5 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $1.4 billion in Q3 2024 to a low of $1.4 million in Q3 2023.
• A 4-year average of $205.4 million and a median of $13.3 million in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments slumped 89.6% in 2023 and surged 100691.56% in 2024, its largest moves.
• Tracing UPC's Short-term Investments over 4 years: stood at $15.3 million in 2021, then dropped by 14.23% to $13.1 million in 2022, then tumbled by 89.6% to $1.4 million in 2023, then surged by 100691.56% to $1.4 billion in 2024.
• Business Quant data shows UPC's Short-term Investments at $1.4 billion in Q3 2024, $2.5 million in Q1 2024, and $1.4 million in Q3 2023.